AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maslow, J. N.
Right arrow Articles by Johnson, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maslow, J. N.
Right arrow Articles by Johnson, J. R.
Antimicrobial Agents and Chemotherapy, September 2004, p. 3618-3620, Vol. 48, No. 9
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.9.3618-3620.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Colonization with Extraintestinal Pathogenic Escherichia coli among Nursing Home Residents and Its Relationship to Fluoroquinolone Resistance

Joel N. Maslow,1,2* Ebbing Lautenbach,2,3,4,5 Thomas Glaze,1 Warren Bilker,3,4,5 and James R. Johnson6

Section of Infectious Diseases, Veterans Affairs Medical Center,1 Division of Infectious Diseases,2 Center for Clinical Epidemiology and Biostatistics,3 Department of Biostatistics and Epidemiology,4 Center for Education and Research on Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania,5 Mucosal and Vaccine Research Center, Veterans Affairs Medical Center, and Department of Medicine, University of Minnesota, Minneapolis, Minnesota6

Received 15 December 2003/ Returned for modification 5 April 2004/ Accepted 25 May 2004


   ABSTRACT
Top
 Abstract
Text
 References
 
In a cross-sectional fecal prevalence survey involving 49 residents of a Veterans Affairs nursing home, 59% of subjects were colonized with extraintestinal pathogenic Escherichia coli (ExPEC), 22% were colonized with adhesin-positive E. coli, and 51% were colonized with fluoroquinolone-resistant E. coli. Among 80 unique isolates, adhesins correlated negatively and aerobactin correlated positively with fluoroquinolone resistance.


   TEXT
Top
 Abstract
 Text
References
 
Nursing home (NH) residents are at increased risk for urinary tract infections (UTIs) and bloodstream infection (12). Gram-negative bacteria (GNB), in particular the subgroup of extraintestinal pathogenic Escherichia coli (ExPEC) strains, cause most such infections (12). ExPEC strains typically express adhesins that promote binding to the uroepithelium and hemolysins that inhibit normal phagocytic killing (1, 10). Conversely, ExPEC isolates are infrequent among collections of normal fecal flora (1, 6, 13).

Antimicrobial resistance among GNB is an increasing problem among hospitalized and ambulatory patients (2) and residents in NHs (16). Resistance to fluroquinolones (FQs), commonly prescribed oral agents, is also an increasing problem, including for E. coli (7-9). Since the fecal flora is the presumed reservoir from which extraintestinal infection isolates arise, we studied whether NH residents manifest high rates of fecal carriage of ExPEC and, if present, whether they are FQ resistant (FQR).

Subjects were prospectively recruited at a 240-bed Veterans Affairs NH. The demographic mix is 50% minority and 1% female, with an average age of 75 years. Informed consent was obtained from the resident's legal guardian if the patient was cognitively impaired. The study was reviewed and approved by the facility Institutional Review Board.

Between March and July 2002, 77 patients were approached for participation: 60 provided informed consent and were enrolled. Five subjects died or were discharged prior to the first sample collection. Rectal swabs were obtained at the time of recruitment and inoculated onto MacConkey agar without antimicrobial additives (nonselective medium). Twenty-five lactose-positive colonies (as available) were arbitrarily selected and inoculated onto nonselective medium and MacConkey agar containing either 8-µg/ml ofloxacin or 1-µg/ml ceftazidime. Antimicrobial susceptibilities and confirmation of species as E. coli were performed by automated testing with the Vitek GNI card (BioMerieux, Hazelwood, Mo.). Expression of extended-spectrum ß-lactamases (ESBLs) was determined by double-disk diffusion testing. The stools from six subjects did not yield E. coli. Thus, swabs from 49 subjects yielded E. coli and were further analyzed. FQR E. coli (FQREC) strains were detected in samples from 25 (51%) subjects; for 11 subjects, all colonies represented FQREC. ESBL expression was detected for only a single strain of FQREC.

Endonuclease analysis of XbaI macrorestriction fragments was performed by pulsed-field gel electrophoresis (PFGE) as described previously (11). Clonal relationships were as defined by Tenover et al. (14). PFGE was performed for all study isolates and yielded a single strain of E. coli for 27 (55%) of the subjects. Twenty-two samples (45%) yielded ≥2 distinct strains of E. coli for a total of 80 isolates.

For each patient, one isolate of each clonal type was subjected to phylogenetic and virulence factor analysis. Isolates were assigned to one of four phylogenetic groups (A, B1, B2, and D) by a triplex PCR-based method (3). Isolates were screened for five key virulence markers: i.e., papA and papC (P fimbriae), sfa/foc (S and F1C fimbriae), afa/dra (DR adhesin), iutA (aerobactin), and kpsII (group 2 capsule) and were defined as ExPEC if positive for ≥2 screening markers (4). Isolates determined to represent ExPEC were tested for 35 virulence markers with established PCR and dot blot-based assays (4, 5). Thirty-six (45%) strains from 29 (59%) subjects qualified as ExPEC (Table 1). Adhesin-encoding genes pap, sfa/foc, and afa/dra were identified among 12 (15%) strains from 11 (22%) subjects.


View this table:
[in this window]
[in a new window]
  		TABLE 1. Prevalence of virulence factors among NH fecal strains

 
The frequency of FQR was analyzed in relation to each virulence factor (Table 1). Aerobactin (iutA)-positive strains were significantly more likely to be FQR (P < 0.001). Conversely, strains that were sat and adhesin positive were more likely to be FQ susceptible (FQS; P = 0.045 and P = 0.063, respectively). Otherwise, there were no significant associations between FQR and the presence of virulence factors.

In this study, we sought to determine whether the increase risk of urinary tract and bloodstream infection among NH residents was due to increased fecal carriage of virulent strains of E. coli, i.e., ExPEC. Additionally, since there are data suggesting that antimicrobial resistance is problematic in this population, we sought to determine whether NH residents frequently carry FQREC and whether such organisms represent ExPEC.

ExPEC strains were observed to colonize the majority (54%) of study subjects, of which the majority represented clonal group B2-2 and carried iutA and kpsII. In contrast, adhesins and hemolysin, virulence factors classically associated with bacteremia and pyelonephritis (10), were detected in a minority of isolates (15%) from 22.4% subjects, a result similar to those from prior studies of normal fecal flora (1, 6, 13), which suggests that carriage of adhesin-positive strains was not spread within the NH population.

One study reported an inverse relationship between the presence of cnf1 and hly (hemolysin) to nalidixic acid resistance (15). In this study, the presence of aerobactin (aer) correlated with FQR, while sat and adhesins correlated with an isolate being FQS. No other virulence factor or group of virulence factors was significantly associated with FQR, although conclusions are limited by the small sample size.

The increased prevalence of iutA- and kpsII-positive (and adhesin-negative) strains has unknown clinical ramifications, primarily since isolates of E. coli causing UTIs and bloodstream infections typically express adhesins and/or hemolysin (10). An unanswered question is whether the presence of iutA- and kpsII-positive strains may increase the risk for future infectious events.

In summary, while adhesin-positive strains are uncommon in NH residents, FQR ExPEC were frequently observed. Since the subjects were from a single Veterans Affairs NH, our study may not be applicable to all NH populations. The clinical importance of adhesin-negative isolates of FQR-ExPEC remains to be determined.


   ACKNOWLEDGMENTS
 
This material is based upon work supported by Office of Research and Development, Medical Research Service, Department of Veterans Affairs (J.N.M. and J.R.J.), a pilot grant from the Philadelphia VA Medical Center Mental Illness Research and Education Center of Excellence (J.N.M.), National Institutes of Health grant AI32783 (J.N.M.), National Research Initiative Competitive Grants Program/United States Department of Agriculture grant 00-35212-9408 (J.R.J.), and Public Health Service grant DK-02987-01 of the National Institutes of Health (E.L.). This study was also supported in part by a Centers for Education and Research on Therapeutics (CERTs) grant (U18-HS10399) from the Agency for Healthcare Research and Quality (E.L.).

Sara Jane Brown and Kristin Owens are acknowledged for technical assistance. Edna Schwab and Ann Farrell are acknowledged for administrative assistance and many helpful discussions.


   FOOTNOTES
 
* Corresponding author. Mailing address: VA Medical Center (151), University and Woodland Ave., Philadelphia, PA 19104. Phone: (215) 823-6020. Fax: (215) 823-5171. E-mail: joel.maslow{at}med.va.gov. Back


   REFERENCES
Top
 Abstract
 Text
 References
 

  1. Archambaud, M., P. Courcoux, and A. Labigne-Roussel. 1988. Detection by molecular hybridization of pap, afa, and sfa adherence systems in Escherichia coli strains associated with urinary and enteral infections. Ann. Inst. Pasteur Microbiol. 139:575-588.[CrossRef][Medline]
  2. Archibald, L., L. Phillips, D. Monnet, J. E. McGowan, F. C. Tenover, and R. Gaynes. 1997. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin. Infect. Dis. 24:211-215.[Medline]
  3. Clermont, O., S. Bonacorsi, and E. Bingen. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.[Abstract/Free Full Text]
  4. Johnson, J. R., M. A. Kuskowski, K. Owens, A. Gajewski, and P. L. Winokur. 2003.Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans. J. Infect. Dis. 188:759-768.[CrossRef][Medline]
  5. Johnson, J. R., and A. L. Stell. 2000. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181:261-272.[CrossRef][Medline]
  6. Kallenius, G., R. Mollby, S. B. Svenson, I. Helin, H. Hultberg, B. Cedergren, and J. Winberg. 1981. Occurrence of P-fimbriated Escherichia coli in urinary tract infections. Lancet ii:1369-1372.
  7. Lautenbach, E., N. O. Fishman, W. B. Bilker, A. Castiglioni, J. P. Metlay, P. H. Edelstein, and B. L. Strom. 2001. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum b-lactam-producing Escherichia coli and Klebsiella pneumoniae. Clin. Infect. Dis. 33:1288-1294.[CrossRef][Medline]
  8. Lautenbach, E., N. O. Fishman, W. B. Bilker, A. Castiglioni, J. P. Metlay, P. H. Edelstein, and B. L. Strom. 2002. Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumonia infections. Arch. Intern. Med. 162:2469-2477.[Abstract/Free Full Text]
  9. Lee, Y. L., T. Cesario, V. McCauly, L. Flionis, and L. Thrupp. 1998. Low-level colonization and infection with ciprofloxacin-resistant gram-negative bacilli in a skilled nursing facility. Am. J. Infect. Control 26:552-557.[CrossRef][Medline]
  10. Maslow, J. N., M. E. Mulligan, K. S. Adams, J. C. Justis, and R. D. Arbeit. 1993. Bacterial adhesins and host factors in the development and outcome of Escherichia coli bacteremia. Clin. Infect. Dis. 17:89-97.[Medline]
  11. Maslow, J. N., A. M. Slutsky, and R. D. Arbeit. 1993. Application of pulsed-field gel electrophoresis to molecular epidemiology, p. 563-572. In D. H. Persing, T. F. Smith, F. C. Tenover, and T. J. White (ed.), Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, D.C.
  12. Nicolle, L. E., L. J. Strausbaugh, and R. A. Garibaldi. 1996. Infections and antibiotic resistance in nursing homes. Clin. Microbiol. Rev. 9:1-17.[Abstract]
  13. Opal, S. M., A. Cross, P. Gemski, and L. W. Lyhte. 1988. Survey of purported virulence factors of Escherichia coli isolated from blood, urine and stool. Eur. J. Clin. Microbiol. Infect. Dis. 7:425-427.[Medline]
  14. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.[Medline]
  15. Vila, J., K. Simon, J. Ruiz, J. P. Horcajada, M. Velasco, M. Barranco, A. Moreno, and J. Mensa. 2002. Are quinolone-resistant uropathogenic Escherichia coli less virulent. J. Infect. Dis. 186:1039-1042.[CrossRef][Medline]
  16. Wiener, J., J. P. Quinn, P. A. Bradford, R. V. Goering, C. Nathan, K. Bush, and R. A. Weinstein. 1999. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 281:517-523.[Abstract/Free Full Text]

Antimicrobial Agents and Chemotherapy, September 2004, p. 3618-3620, Vol. 48, No. 9
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.9.3618-3620.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maslow, J. N.
Right arrow Articles by Johnson, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maslow, J. N.
Right arrow Articles by Johnson, J. R.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS